Annual EBITDA
-$64.35 M
-$6.30 M-10.86%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual EBITDA is -$64.35 million, with the most recent change of -$6.30 million (-10.86%) on December 31, 2023.
- During the last 3 years, LXEO annual EBITDA has fallen by -$59.76 million (-1302.55%).
- LXEO annual EBITDA is now -1302.55% below its all-time high of -$4.59 million, reached on December 1, 2020.
Performance
LXEO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$28.95 M
-$8.24 M-39.78%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly EBITDA is -$28.95 million, with the most recent change of -$8.24 million (-39.78%) on September 30, 2024.
- Over the past year, LXEO quarterly EBITDA has dropped by -$9.35 million (-47.71%).
- LXEO quarterly EBITDA is now -123.65% below its all-time high of -$12.94 million, reached on June 30, 2023.
Performance
LXEO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$84.47 M
-$9.35 M-12.45%
September 30, 2024
Summary
- As of February 8, 2025, LXEO TTM EBITDA is -$84.47 million, with the most recent change of -$9.35 million (-12.45%) on September 30, 2024.
- Over the past year, LXEO TTM EBITDA has dropped by -$19.69 million (-30.40%).
- LXEO TTM EBITDA is now -458.13% below its all-time high of -$15.13 million, reached on June 30, 2022.
Performance
LXEO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LXEO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.9% | -47.7% | -30.4% |
| 3 y3 years | -1302.5% | -47.7% | -30.4% |
| 5 y5 years | -1302.5% | -47.7% | -30.4% |
LXEO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.1% | at low | -123.7% | at low | -458.1% | at low |
| 5 y | 5-year | -1302.5% | at low | -123.7% | at low | -458.1% | at low |
| alltime | all time | -1302.5% | at low | -123.7% | at low | -458.1% | at low |
Lexeo Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.95 M(+39.8%) | -$84.47 M(+12.4%) |
| Jun 2024 | - | -$20.71 M(-2.2%) | -$75.12 M(+11.5%) |
| Mar 2024 | - | -$21.17 M(+55.1%) | -$67.35 M(+4.7%) |
| Dec 2023 | -$64.35 M | -$13.65 M(-30.4%) | -$64.34 M(-0.7%) |
| Sep 2023 | - | -$19.60 M(+51.4%) | -$64.78 M(+4.7%) |
| Jun 2023 | - | -$12.94 M(-28.7%) | -$61.86 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$18.16 M(+29.0%) | -$64.06 M(+39.6%) |
| Dec 2022 | -$58.04 M(+14.7%) | -$14.08 M(-15.6%) | -$45.90 M(+44.2%) |
| Sep 2022 | - | -$16.68 M(+10.2%) | -$31.82 M(+110.2%) |
| Jun 2022 | - | -$15.13 M | -$15.13 M |
| Dec 2021 | -$50.61 M(+1003.1%) | - | - |
| Dec 2020 | -$4.59 M | - | - |
FAQ
- What is Lexeo Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual EBITDA year-on-year change?
- What is Lexeo Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly EBITDA year-on-year change?
- What is Lexeo Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Lexeo Therapeutics?
- What is Lexeo Therapeutics TTM EBITDA year-on-year change?
What is Lexeo Therapeutics annual EBITDA?
The current annual EBITDA of LXEO is -$64.35 M
What is the all time high annual EBITDA for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual EBITDA is -$4.59 M
What is Lexeo Therapeutics annual EBITDA year-on-year change?
Over the past year, LXEO annual EBITDA has changed by -$6.30 M (-10.86%)
What is Lexeo Therapeutics quarterly EBITDA?
The current quarterly EBITDA of LXEO is -$28.95 M
What is the all time high quarterly EBITDA for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly EBITDA is -$12.94 M
What is Lexeo Therapeutics quarterly EBITDA year-on-year change?
Over the past year, LXEO quarterly EBITDA has changed by -$9.35 M (-47.71%)
What is Lexeo Therapeutics TTM EBITDA?
The current TTM EBITDA of LXEO is -$84.47 M
What is the all time high TTM EBITDA for Lexeo Therapeutics?
Lexeo Therapeutics all-time high TTM EBITDA is -$15.13 M
What is Lexeo Therapeutics TTM EBITDA year-on-year change?
Over the past year, LXEO TTM EBITDA has changed by -$19.69 M (-30.40%)